/Intuitive%20Surgical%20Inc%20location%20sign-by%20Sundry%20Photography%20via%20iStock.jpg)
Valued at a market cap of $160.8 billion, Intuitive Surgical, Inc. (ISRG) develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The company markets and develops products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care. Headquartered in Sunnyvale, California, the company is expected to unveil its fiscal Q1 2025 earnings results after the market closes on Tuesday, Apr. 22.
Ahead of this event, analysts expect ISRG to report adjusted earnings of $1.36 per share, up 17.2% from $1.16 per share in the previous year's quarter. It has surpassed Wall Street's bottom-line estimates in the past four quarters. In Q4 2024, Intuitive Surgical exceeded the consensus EPS estimate by 36.9%.